Navigation Links
Conseco Completes Divestiture of Old Block of Fixed and Equity-Indexed Annuities
Date:10/12/2007

in claims adjudication and continued automation and rationalization of operating systems; (v) performance of our investments; (vi) our ability to identify products and markets in which we can compete effectively against competitors with greater market share, higher ratings, greater financial resources and stronger brand recognition; (vii) the ultimate outcome of lawsuits filed against us and other legal and regulatory proceedings to which we are subject; (viii) our ability to remediate the material weakness in internal controls over the actuarial reporting process that we identified at year-end 2006 and to maintain effective controls over financial reporting; (ix) our ability to continue to recruit and retain productive agents and distribution partners and customer response to new products, distribution channels and marketing initiatives; (x) our ability to achieve an upgrade of the financial strength ratings of our insurance company subsidiaries as well as the potential impact of rating downgrades on our business; (xi) the risk factors or uncertainties listed from time to time in our filings with the Securities and Exchange Commission; (xii) regulatory changes or actions, including those relating to regulation of the financial affairs of our insurance companies, such as the payment of dividends to us, regulation of financial services affecting (among other things) bank sales and underwriting of insurance products, regulation of the sale, underwriting and pricing of products, and health care regulation affecting health insurance products; (xiii) general economic conditions and other factors, including prevailing interest rate levels, stock and credit market performance and health care inflation, which may affect (among other things) our ability to sell products and access capital on acceptable terms, the returns on and the market value of our investments, and the lapse rate and profitability of policies; and (xiv) changes in the Federal income tax laws and regulati
'/>"/>
SOURCE Conseco, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. iGATE Completes Phase I Testing Of Meningitis Vaccine
2. Delhi Hospital Completes 100 Liver Transplants
3. Roche Completes Acquisition of BioVeris
4. Spirulina may be the next immune boost on the block
5. Blocked viens block eye sight
6. Protein Fragments Blocking Cures Alzheimers Disease
7. Multiple Sclerosis Can Be Treated By Blocking Fat Hormone
8. Angiotensin-II-receptor blockers - Treat kidney failure
9. Re-blockage of heart arteries prevented by vitamins
10. New device for detecting artery blockages
11. Gene block keeps mice from increasing weight
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2014)... San Diego, Calif. (April 18, 2014) ― A new ... analyzing weekly patterns in health-related Google searches reveals ... public health strategies. , Investigators from San ... University, and the Monday Campaigns, analyzed "healthy" Google searches ... health-related, e.g., "healthy diet") originating in the U.S. from ...
(Date:4/17/2014)... The presence of chronic inflammation in benign ... prostate cancer, and this association was found even ... according to a study published in Cancer ... the American Association for Cancer Research. , An ... participants of the placebo arm of the Prostate ...
(Date:4/17/2014)... Scientists have identified new pain relief targets that ... pain. BBSRC-funded researchers at King,s College London made ... nerves in the periphery of the body. , ... and identifying mechanisms underlying pain generation and our ... related side effects." , One potential side effect ...
(Date:4/17/2014)... issue of Experimental Biology and Medicine ... Gaskins and Paul Kenis in the Institute of ... University of Illinois Urbana-Champaign describe their recent work ... a variety of cell functions including energy metabolism, ... roles in regulating normal cellular behavior, redox status ...
(Date:4/17/2014)... in the April issue of Immunity , Kevin ... Medical Research, says it,s time to take a fresh ... sepsis, which kills millions worldwide every year, including ... released into the bloodstream to fight an injury or ... for maintaining good health without inflammation, wounds and ...
Breaking Medicine News(10 mins):Health News:New research shows people are thinking about their health early in the week 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 3Health News:New pain relief targets discovered 2Health News:Live cell imaging reveals distinct alterations of subcellular glutathione potentials 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2
... IDXX ), announced today that its Board of ... additional four million,shares of its common stock under its ... open market or in negotiated transactions.,These shares are in ... 2007, under a previous Board authorization. The timing and,amount ...
... Consumer,Healthcare, a division of Wyeth (NYSE: WYE ... named Executive Vice President, Global Research and,Development (R&D), ... the consumer division,s global R&D organization. In her ... R&D efforts to,effectively bring new products to market ...
... Researchers find chronic worry impairs immune response to cancer-causing ... levels of daily stress could explain why some women ... cervical cancer, a new study suggests. , Scientists ... women, all diagnosed with cervical dysplasia (precancerous cervical lesions), ...
... Precious Medicare Dollars on Trial Lawyers and,Focus on Needy ... Blunt (Mo.) today praised President Bush,s proposal that would ... is clear that without substantial reforms, Medicare will not ... The legislation put,forth by the president is the needed ...
... million in bonuses and incentives, ADA, Mich., Feb. ... $1.072 billion, the fifth consecutive year in which the,company ... from the previous year,s sales of $1.12 billion, which ... affected minimally by actions the company took to,terminate the ...
... media outreach for TRIA, the first hair removal ... to enter U.S. home-based beauty device market, NEW ... Rpr Marketing Communications as its U.S. agency of record ... U.S. home-based beauty,device market., SpectraGenics, Inc. is a ...
Cached Medicine News:Health News:Wyeth Consumer Healthcare Names New Head of Global R&D 2Health News:Daily Stress May Raise Women's Risk of Cervical Cancer 2Health News:Daily Stress May Raise Women's Risk of Cervical Cancer 3Health News:Blunt Praises President's Plan to Save Medicare 2Health News:Quixtar Announces Fifth Consecutive Year of Billion-Dollar Sales 2Health News:Spectragenics Names Rpr Marketing Communications Agency of Record 2
(Date:1/15/2014)... , Jan. 15, 2014 Most osteoporosis patients want ... a recent online survey* sponsored by Mission Pharmacal Company. ... National Osteoporosis Foundation online support community, revealed that 74 ... that comes in a form other than a pill ...
(Date:1/15/2014)... 2014  Novation, the leading health care supply chain expertise, ... reseller (VAR) national contracts that expand its portfolio to ... lower costs. These include manufacturer product and service agreements, ... and ongoing IT consulting support. New ...
(Date:1/15/2014)... , Jan. 15, 2014  Humberto C. Antunes,  Galderma  ... Award" from the Journal of Drugs in Dermatology ... Clinical Conference (ODAC). The event is January 17-20, 2014, at the ... . The ODAC is a ...
Breaking Medicine Technology:Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 2Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 3New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4
... , FRIMLEY, England, December 8 , ... Treatment Effectiveness,in the Trial, in Patients With Newly-Diagnosed Disease(1) , ... the Disease on nilotinib (300mg Twice-Daily and 400mg Twice-Daily) Than on,imatinib 400mg ... Only a Small Number of Patients,Discontinued Due to Adverse Events(1) , ...
... ... , ... - Will Use BrainTrack,s College Campus Data to Enhance Elsevier Evolve,Website Registrations ... technical and,medical information products and services, and BrainTrack,( http://www.braintrack.com ), the widely referenced ...
Cached Medicine Technology:Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 3Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 4Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 5Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 6Elsevier Selects BrainTrack Directory as Supplier of College Data 2Elsevier Selects BrainTrack Directory as Supplier of College Data 3Elsevier Selects BrainTrack Directory as Supplier of College Data 4
Microforceps : Eckardt End & Side Gripping Forceps...
Blunt tipped forceps wlth a small grasping platform on each tip. For grasping fine membranes or grasping membranes adherent to the retinal surface....
Microforceps: Spaid Pic Forceps...
Blunt tipped forceps with small, slightly pointed grasping platforms on each tip. For general purpose (fine) membrane grasping and grasping membranes adherent to the retlnal surface....
Medicine Products: